Objective. To determine the role of inflammatory biomarkers at 2 years post-anterior cruciate ligament (ACL) injury to predict radiographic knee osteoarthritis (OA) and magnetic resonance imaging (MRI)-defined knee OA at 5 years postinjury, with a secondary aim of estimating the concordance of inflammatory biomarkers assessed by MRI and synovial fluid (SF) analysis.
INTRODUCTION
Anterior cruciate ligament (ACL) injury is a common and serious joint injury leading to ~200,000 ACL reconstructions each year in the US alone (1) . The purpose of ACL reconstruction is to improve joint stability and reduce the risk of subsequent development of knee osteoarthritis (OA) (1) . However, long-term radiographic and epidemiologic studies suggest that ACL reconstruction may not protect against the development of posttraumatic OA, with reported OA rates varying between 10% and 90% of patients who experienced ACL injury (2) (3) (4) .
Trauma-induced cytokine response and local inflammation after knee injury may be important in the development of posttraumatic OA (5) . In the Knee ACL Nonsurgical versus Surgical Treatment (KANON) study, a randomized controlled trial, highly increased synovial fluid (SF) levels of inflammatory cytokines in the injured joint were observed early after trauma, and some levels remained increased up to 5 years after injury (5) . In knees without radiographically evident OA (ROA), the risk of cartilage loss is markedly increased when magnetic resonance imaging (MRI)-defined joint effusion and synovitis are present (6) . Based on these observations and given that ACL injury leads to severe local inflammation at the time of injury, one may argue that persistent inflammation following trauma or surgery can potentially increase the risk of subsequent OA development.
Thus, our primary aim in the present study was to determine the role of inflammation at 2 years post-ACL injury in predicting ROA and MRI-defined OA (MROA) in the knee at 5 years postinjury. As a secondary aim, we examined the concordance between inflammation as determined by MRI and biomarkers from SF.
PATIENTS AND METHODS
KANON study and subject inclusion. We used data from the KANON trial (International Standard Randomised Controlled Trial no. 84752559 [http://www.controlled-trials.com]), which compared a surgical treatment strategy to a nonsurgical treatment strategy for acute ACL injuries in 121 young, active individuals (4) .
For the present analysis, we included patients with available data on inflammation biomarkers in serum or SF and MRI at 2 years postinjury, as well as ≥1 of our 2 outcome measures (ROA or MROA at 5 years), as described below. The decision to analyze the 2-year postinjury time point in regard to inflammatory activity based on MRI and SF biomarkers (as opposed to earlier time points) was due to the overarching goal of identifying patients that experience persistent or prolonged inflammation. All patients exhibited acute posttraumatic inflammation in their joints, as manifested by marked changes in imaging or laboratory results. As we recently reported, surgery imposed a subsequent trauma to the knee joint, with secondary inflammatory peaks observed postsurgery (5) .
For the prediction analysis, 113 individuals were included in the assessments using serum biomarkers, and 78 individuals were included in the assessments using SF; in the concordance analysis, 81 individuals were included in the assessments using only SF and MRI markers. The concordance analysis between MRI markers and SF markers was performed cross-sectionally only (i.e., at the 2-year time point). Three patients had 2-year data but not 5-year data. Our decision to focus the concordance analysis on SF markers and exclude serum biomarkers was based on the fact that MRI scans, radiographs, and SF markers all reflect local processes of the injured knee, whereas systemic fluids such as serum reflect processes of the entire body. This study was approved by the Regional Ethical Review Board at Lund University.
Radiographic acquisition and assessment. Fluoroscopically guided frontal posteroanterior radiographs with weight bearing, plus lateral radiographs of the tibiofemoral (TF) compartment and patella skyline view radiographs were obtained at baseline and at 5 years. For the injured (index) knee, an experienced musculoskeletal radiologist (FWR), who was blinded with regard to the treatment allocation and clinical data, graded baseline and 5-year radiographs for osteophytes (TF and patellofemoral [PF] compartments) and joint space narrowing (JSN) (TF compartment only), according to the Osteoarthritis Research Society International (OARSI) atlas (7) . Kappa values for agreement between radiographic assessments of osteophyte formation and JSN obtained using Kellgren/Lawrence (K/L) grading (8) versus using OARSI atlas grading commonly range between 0.70 and 0.88 (9, 10) . MRI acquisition. MRI was performed using a 1.5T system (Gyroscan Intera; Philips Medical Systems). The MRI pulse sequence protocol has been described in detail (11) and included a sagittal 3-dimensional (3-D) fast low-angle water excitation sequence, sagittal T2*-weighted 3-D gradient echo sequences, a sagittal and coronal dual-echo turbo spin-echo sequence, and sagittal and coronal short tau inversion recovery sequences.
MRI assessment. All available MRIs were read by a musculoskeletal radiologist (FWR) according to the Anterior Cruciate Ligament OsteoArthritis Scoring (ACLOAS) system (12) . ACLOAS was determined by analyzing nonenhanced MRI scans and using an assessment of inflammation that includes whole-joint synovitis based on signal changes in Hoffa's fat pad (referred to as Hoffa-synovitis) and a composite measure of the amount of intraarticular joint fluid and synovial thickening on fluid-sensitive images (referred to as effusion-synovitis). Intraobserver reliability (kappa) for assessment of effusion-synovitis for all time points scored was 0.85 (95% confidence interval [95% CI] 0.78, 0.92), and for Hoffa-synovitis it was 0.54 (95% CI 0.42, 0.66). Interobserver reliability was 0.75 (95% CI 0.66, 0.84) and 0.60 (95% CI 0.48, 0.72), respectively (12) .
Inflammation biomarkers in serum and SF. Serum levels and SF levels of interleukin-1β (IL-1β), IL-6, IL-8, IL-10, IL12p70, interferon-γ (IFNγ), and tumor necrosis factor (TNF) were previously assessed in the KANON samples using a Multiplex Human Pro-inflammatory 7-plex immunoassay (Meso Scale Discovery) (5) . In a large proportion of the samples, cytokine concentrations were below their lower limits of quantification (LLOQ) and had high coefficients of variation (CVs) (5) . For this reason, only the data on IL-6, IL-8, IL-10, IL-12p70, IFNγ, and TNF from serum and all of these except for IL-12p70 from SF were accepted for further analysis in the present study. Values below the LLOQ were imputed using the LLOQ value divided by 2. All biomarker values were log 10 -transformed before analysis.
ROA and MROA outcome measures. To define patients in the KANON cohort as having developed ROA after 5 years, 1 of the following 3 criteria had to be fulfilled in either the medial or lateral TF compartment or in the PF compartment based on OARSI grading: JSN of grade 2 or higher (TF compartment only), sum of the 2 marginal osteophyte grades from the same compartment of ≥2, or JSN of grade 1 in combination with grade 1 osteophytes in the same compartment (TF compartment only) (13) . MROA was defined based on the criteria described by Hunter et al (14) .
Analytical approach. We used 4 definitions of structural knee OA: 1) whole-joint MROA (TF joint MROA and/or PF joint MROA), 2) whole-joint ROA (TF joint ROA and/or PF joint ROA), 3) TF joint OA (either TF joint ROA or TF joint MROA, or both), and 4) PF joint OA (either PF joint ROA or PF joint MROA, or both).
Three predictive models were evaluated for each outcome: model 1 that included Hoffa-and effusion-synovitis (MRI features only), model 2 that included all inflammatory biomarkers, and model 3 that included models 1 and 2. Age and sex were included as additional predictors in all models. Biomarkers with >70% of values below the LLOQ were included as categorical (below or above LLOQ) in the predictive models.
We used 2 approaches for developing predictive models: a logistic regression model with the lasso method to select predictors and, repeating the analyses using a more flexible model, classification and regression trees (CARTs) as implemented in the Classification and Regression Training package (15) . We used repeated (10 times) 5-fold cross-validation for resampling, and the 1-standard deviation criterion was used to select the optimal model. The models were optimized to maximize either the area under the receiver operating characteristic curve (AUC) or sensitivity. The predictive accuracy of the model was assessed with AUC, sensitivity, and specificity, reported with 95% CIs. An additional analysis was performed including treatment (surgical or nonsurgical) as a predictor.
To evaluate concordance between MRI inflammatory features and SF inflammation biomarkers, we used regression models. The MRI scores (for Hoffa-or effusion-synovitis, categorized into values of 0, 1, or ≥2) were used as the independent variable, and SF inflammation biomarkers were used as the dependent variable. For the few values that were below the LLOQ for TNF and IL-8, linear regression with log 10 values of * MROA = magnetic resonance imaging (MRI)-defined osteoarthritis; ROA = radiographic OA. † Tibiofemoral (TF) joint MROA was defined as described by Hunter et al (14) , requiring presence of a definite osteophyte and full thickness cartilage loss (or either of these 2 features), in addition to 2 or more of the following features: 1) subchondral bone marrow lesion or cyst not associated with meniscal or ligamentous attachments, 2) meniscal subluxation, maceration, or degenerative (horizontal) tear, 3) partial-thickness cartilage loss (where full-thickness loss is not present), or 4) bone attrition. ‡ Definition of patellofemoral (PF) joint MROA requires presence of a definite osteophyte and partial-or full-thickness cartilage loss in at least 1 of 4 patellofemoral subregions. ROA was defined as either TF joint OA, PF joint OA, or both TF joint OA and PF joint OA.
the biomarker was used. For IL-6, IL-10, and IFNγ (with a high proportion of values below the LLOQ), a 2-step approach was applied. First, a logistic regression model was used to estimate whether the MRI marker was associated with having biomarker values above the LLOQ. For values above the LLOQ, a negative binomial regression was applied, and intensity ratios were calculated. All statistical analyses were conducted using Stata release 14 (StataCorp).
RESULTS
Demographic and descriptive data. The 113 individuals included in the prediction analyses had a mean ± SD age of 26.1 ± 4.9 years, 28 patients (25%) were women, and the right knee was the injured knee in 61 cases (54%). The mean ± SD body mass index (BMI) was 24.4 ± 3.2 kg/m 2 . Five years postinjury, 29 patients (26%) had whole-joint ROA, 13 patients (12%) had TF joint ROA, and 22 patients (20%) had PF joint ROA. Whole-joint MROA was seen in 37 patients (33%). According to subtypes, 35 patients (31%) had TF joint MROA and 10 patients (9%) had PF joint MROA. While the MRI definition of wholeknee and TF joint OA categorized more knees as OA-positive compared to the radiography definition (37 versus 29 with whole-knee OA, respectively, and 35 versus 13 with TF joint OA), the opposite was the case for the PF joint definition of OA, with only 10 knees being MROA-positive and 22 having PF joint ROA (Table 1) . Two years postinjury, 22 patients (19%) had no signs of Hoffa-synovitis (i.e., grade 0), 58 patients (51%) had grade 1 Hoffa-synovitis, and 33 patients (29%) had grade 2 or 3 Hoffa-synovitis. Most patients (71%) did not show any signs of effusion-synovitis at 2 years, while 26 patients (23%) had grade 1 effusion-synovitis, and 7 patients (6%) had grade 2 or 3 effusionsynovitis.
At 2 years, there were 113 patients with serum samples and 81 with SF samples (see Supplementary Table 1 , on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley. com/doi/10.1002/art.40687/abstract). All patients with serum samples and 78 of those with SF samples had corresponding MRI-defined inflammation and at least 1 structural OA outcome at 5 years.
Prediction of OA.
The overall discriminatory accuracy of biomarkers (models 1-3) in predicting knee OA at 5 years, according to the aforementioned 4 definitions, was weak. In the model maximizing AUC using logistic regression, values ranged between from 0.44 (model 1: MRI features only predicting ROA) to 0.69 (model 2b: SF biomarkers only predicting PF joint OA) ( Table 2) .
Results were comparable in models 1-3, maximizing sensitivity using logistic regression (Supplementary Table 2 , http:// onlinelibrary.wiley.com/doi/10.1002/art.40687/abstract). Calibration of all models was poor (data not shown). Similar results were obtained when using a more flexible CART model Table 1 for other definitions).
maximizing the AUC (Supplementary Table 3 ) and maximizing sensitivity (Supplementary Table 4 ). Comparable results were observed when including a treatment variable as a predictor (Supplementary Table 5 ).
Concordance between MRI and SF inflammation biomarkers. With regard to markers assessed in SF, a statistically significant association was observed only between IL-8 level and effusion-synovitis. The results of the linear regression analysis for IL-8 and TNF are presented in Table 3 . No statistically significant associations were observed between IL-6, IL-10 or IFNɣ and inflammatory MRI markers (Supplementary Table 6 ).
DISCUSSION
In this prospective cohort of patients with acute ACL injuries, selected local and systemic inflammation biomarkers derived from SF, serum, and MRI at 2 years did not predict structural knee OA at 5 years, regardless of treatment strategy. We used 4 outcome definitions of structural OA in 3 separate prediction models, including MRI results only, molecular biomarkers only, and a combination of the two.
In the same cohort, we reported a marked elevation of aggrecan ARGS neoepitope and inflammatory biomarker concentrations in SF shortly after injury, with decreasing concentrations over time (5) . At 5 years, however, the TNF concentration in SF still remained higher than the reference level, indicative of extended local inflammation. A recent report from the KANON trial described higher inflammatory biomarker concentrations in SF from the injured knee at 4 months, 8 months, and 5 years, among subjects randomized to undergo early ACL reconstruction, suggesting that surgery constitutes a second trauma to the acutely injured joint (16) .
Increasing evidence suggests that low-grade inflammation plays an important role in nontraumatic OA (6, 17) , though the role of inflammation in posttraumatic OA is less clear. Some authors have suggested that targeting inflammation posttrauma may have the potential to reduce the risk of OA (18) .
While OA may be defined structurally, clinically, or by using both constructs, here we focused on structural OA as the outcome. ROA is classically defined as meeting the criterion of a K/L grade of ≥2. We used a simulated K/L grade based on readings according to the OARSI atlas (7) that included the PF joint. In addition, we applied an MRI definition of OA based on an exercise using the Delphi method (14) .
As expected, the proportion of patients with whole-joint and TF joint MROA at 5 years was higher compared to patients with whole-joint and TF joint ROA. However, we observed an unexpectedly higher proportion of patients with PF joint ROA compared to those with PF joint MROA. The explanation for this may be multifold, but it is likely due to the fact that the radiography definition of PF joint OA required only a minimum sum of 2 from 4 possible marginal osteophytes, whereas the MRI definition required the simultaneous presence of a definite osteophyte and concomitant cartilage loss in the PF joint. Supplementary Figures 1 and 2 (http://onlinelibrary.wiley.com/ doi/10.1002/art.40687/abstract) illustrate potential causes of the discrepancies between imaging methods, particularly for PF joint OA.
The concordance between MRI inflammation markers and SF cytokines, both considered to represent local inflammation, was surprisingly weak. The only statistically significant finding was that patients who had higher grades of effusion-synovitis showed, on average, higher SF levels of IL-8. One possible explanation may be our limited understanding of low-grade inflammation of the knee, resulting in a challenge to define and measure the inflammation using MRI and molecular biomarkers. The imaging measures used here are sensitive but nonspecific for inflammation, and the SF biomarkers, while considered to indicate inflammation, may not be the ones involved in this particular form or phase of OA. Another possible explanation could be that MRI markers change more slowly compared to SF cytokines.
Some limitations of our study should be noted. The KANON trial was conducted to find clinically relevant differences between 2 treatment strategies at 2 years postinjury, and our small sample size and relatively short follow-up limit the ability to draw firm conclusions. Inflammatory biomarker results were not available for all individuals, and some SF markers had a high proportion of concentrations below the LLOQ. Other important risk factors for OA, such as meniscus injury/ surgery and osteochondral injury, were not analyzed. Despite the use of commonly reported inflammatory biomarkers and well-described imaging features of inflammation and outcomes, it is possible that markers not assessed here may provide different results. SF samples were not available for all patients at 2 years, which may have introduced some bias. An explanation for unavailable samples was not recorded, but it may be due to a patient's refusal to undergo arthrocentesis or an unsuccessful attempt at fluid aspiration. Another limitation is that only 25% of our cohort were female, despite the fact that females have a high risk of ACL injury. For this reason, we included sex as a predictor in our models. Although some of the observed associations and 95% CIs in the prediction analysis were >0.5, we do not interpret the range of values included in 95% CIs as representing any clinically useful discriminatory ability. This seemed even clearer when evaluating the sensitivity and specificity of the models. Finally, we did not include BMI in our models given that mean BMI in these young patients was normal and the standard deviation small. A particular strength of this study is the inclusion of patients treated both surgically and nonsurgically.
In our cohort of patients with acute ACL injury, inflammation at 2 years defined by MRI and selected local and systemic inflammatory biomarkers did not predict structural OA as defined by radiography and MRI at 5 years posttrauma. Additionally, the concordance of inflammatory biomarkers assessed by MRI and in SF was found to be surprisingly weak. Additional studies with longer follow-up will be needed to more firmly define the role of inflammation in OA development following acute ACL injury.
